|
Jul 24
|
Novo Nordisk defeated in Wegovy patent dispute by Viatris
|
|
Jul 24
|
Coagulation Factor Deficiency Market Research Report 2025 | Advancements in Long-Acting Clotting Factors and Gene Therapies Propel Growth - Global Forecast to 2035
|
|
Jul 23
|
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
|
|
Jul 23
|
Jim Cramer Says He Does Not Want Novo Nordisk Due to Tariffs
|
|
Jul 23
|
India's Dr Reddy's plans to launch generic obesity drugs in 87 countries next year, CEO says
|
|
Jul 23
|
Americans Are Turning To DIY Weight Loss Injections to Dodge $1,000+ Monthly Drug Costs
|
|
Jul 23
|
Amgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?
|
|
Jul 23
|
Here's Why Novo Nordisk (NVO) is a Strong Value Stock
|
|
Jul 23
|
The protein boom is only beginning
|
|
Jul 22
|
NVIDIA's Story Keeps Getting Brighter
|
|
Jul 22
|
Pharma sector outlook as Trump's drug tariff deadline looms
|
|
Jul 22
|
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
|
|
Jul 22
|
Richmond, B.C. named Canada's Most Active Community
|
|
Jul 22
|
2 Beaten-Down Dividend Growth Stocks to Buy on the Dip
|
|
Jul 21
|
Should You Invest in This Under-the-Radar Weight Loss Stock?
|
|
Jul 21
|
2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade
|
|
Jul 21
|
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer
|
|
Jul 21
|
Fangzhou and Novo Nordisk link on chronic disease management
|
|
Jul 21
|
A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money
|
|
Jul 18
|
Can Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?
|